Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

11
Agenzia sanitaria e sociale regionale Bilbao 26th June 2012 Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach Luciana Ballini Luca Vignatelli, Susanna Maltoni, Antonella Negro, Fabio Trimaglio, Roberto Grilli Methods in HTA – Health outcomes http://asr.regione.emilia-romagna.it

description

Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach Luciana Ballini

Transcript of Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Page 1: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

Bilbao 26th June 2012

Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Luciana BalliniLuca Vignatelli, Susanna Maltoni, Antonella Negro, Fabio Trimaglio, Roberto Grilli

Methods in HTA – Health outcomes

http://asr.regione.emilia-romagna.it

Page 2: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

eAppropriateness of

FDG-PET in oncology: 3rd updateSince 2001 a permanent research activity alongside the development and diffusion

of the technologyAn obsession ?

• To reason on diagnostic-therapeutic strategies, rather than simply on diagnostic test

• To address research gaps (clinical effectiveness)

• To test a new methods for working groups developing diagnostic recommendations

… or an opportunity

Page 3: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e Appropriateness of a diagnostic test

• Initial diagnostic assessment with subsequent therapeutic approach

• The potential of the new test to modify initial diagnostic assessment (e.g. stage of disease)

• The change in management following change of diagnostic assessment

• The diagnostic accuracy of the new test

• The resulting improvement in patients’ outcome due to change in therapeutic approach induced by new test’s results

Available evidence

Rationale

?

The value of any medical test is ultimately measured by whether the information it provides affects patient-relevant outcomes (Bossuyt 2010)

Schunemann et al BMJ 2008;336:1106-1110.

Page 4: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

PALLIATIVE

Diagnostic accuracy

Diagnostic efficacy

TEST POSITION

Outcomes trade off

Change in Management

SIGNIFICANT NEGLIGIBLE

Treatment options effectiveness

CURATIVE

harms versus benefits

Impact on patients’

outcomes

APPROPRIATENESS

CRITERIA

Initial diagnostic assessment

NOT MODIFIABLE MODIFIABLE

Consequentialist Approach

Page 5: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

The consequentialist approach at work : information provided to the panel

Page 6: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

Rationale: Preoperative chemo/radio therapy reduces tumour mass but

increases risk of post-operative mortality (ESMO 2010). Early identification of

non responders could avoid futile treatment and unnecessary risks

Treatment effectiveness: Preoperative chemo/radio therapy

improves 2 year survival by 13% (absolute difference) compared to

surgical treatment only (Gebski Lancet Oncology 2007)

CLINICAL QUESTION:

Role of FDG-PET in early response to pre-operative chemoradiation of patients

treated for locally advanced esophageal cancer

RESEARCH QUESTION: FDG-PET as replacement

Is FDG-PET accurate in evaluating early response to pre-operative chemoradiation of

patients treated for locally advanced esophageal cancer ?

PALLIATIVE

Change in Management

SIGNIFICANT NEGLIGIBLE

Treatment options effectiveness

CURATIVE

Initial diagnostic assessment

NOT MODIFIABLE MODIFIABLE

Page 7: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

PATIENT IMPORTANT OUTCOMES

Diagnostic accuracy

LEVEL OF EVIDENCE

Outcomes importance

Schunemann et al BMJ 2008;336:1106-1110.

Page 8: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

INAPPROPRIATENot good enough

7

5

8

7

Median scores of

importance

Diagnostic efficacy

TEST POSITION

Outcomes trade off

harms versus benefits

APPROPRIATENESS

CRITERIA

Page 9: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

28/55 (50.9%) resolved at first voting round

16/55 (29.1%) resolved at second voting round

11/55 (20%) persistent disagreement

55 questions

11 appropriate

4 indeterminate

13inappropriate

12 inappropriate No rationale

27 Disagreement

5 appropriate

9 inappropriate

11 disagreement

2 uncertain

9 light Disagreement

2 StrongDisagreement

RAND/UCLA Appropriateness Method: Results 7 panels (60 experts) – 7 tumours Lung

Breast Head & Neck Esophageal Colo-rectal

H LymphomaNH Lymphoma

Page 10: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e Was the approach followed by the panels ?

41

21

2

11

14

0

2

4

6

8

10

12

14

16

18

20

of

qu

esti

on

s

Observed (RAND)

Expected(GRADE)

YES (40 questions)

NO (4 questions)

Yes in 73% of questions(considering also the 11 unresolved questions)

Page 11: Bringing patients’ outcome at the forefront in HTA of diagnostic tests using the GRADE approach

Agen

zia s

anita

ria e

soc

iale

regi

onal

e

The panelists

[email protected]

Thank you

http://asr.regione.emilia-romagna.it